Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.
暂无分享,去创建一个
Tom Dormans | M. Nijsten | J. Twisk | A. Girbes | D. D. de Lange | H. Endeman | J. Kesecioglu | L. Bormans | A. Beishuizen | E. M. van de Garde | Jos W Twisk | J. Schouten | Joost L van Pelt | T. Dormans | A. Reidinga | E. D. de Jong | J. V. van Oers | Dylan W de Lange | Albertus Beishuizen | Evelien de Jong | Jozef Kesecioglu | P. Vos | H. Kemperman | Armand R Girbes | Hans Kemperman | Jos A van Oers | Piet Vos | Wytze J Vermeijden | Lenneke E Haas | Bert G Loef | Gertrude C van Melsen | Yvette C Kluiters | Maarten J van den Elsen | Jeroen A Schouten | Jörn O Streefkerk | Hans G Krabbe | Hans Kieft | Georg H Kluge | Veerle C van Dam | Joost van Pelt | Laura Bormans | Martine Bokelman Otten | Auke C Reidinga | Henrik Endeman | Ewoudt M W van de Garde | Anne Marie G A de Smet | Maarten W Nijsten | B. Loef | A. M. D. de Smet | Veerle C. Van Dam | G. Kluge | L. Haas | Wytze J. Vermeijden | J. O. Streefkerk | H. Kieft | Yvette Kluiters | M. Otten | M. J. van den Elsen | G. C. van Melsen | M. J. van den Elsen | H. Krabbe | W. Vermeijden | A. D. de Smet
[1] M. Levy,et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008 , 2007, Intensive Care Medicine.
[2] M. Christ-Crain,et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial , 2004, The Lancet.
[3] D. Pittet,et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. , 2001, American journal of respiratory and critical care medicine.
[4] R. Paladini,et al. Procalcitonin as a prognostic and diagnostic tool for septic complications after major trauma* , 2009, Critical care medicine.
[5] B. Bein,et al. Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial , 2009, Critical care.
[6] F. Tubach,et al. Procalcitonin to Guide Initiation and Duration of Antibiotic Treatment in Acute Respiratory Infections: An Individual Patient Data Meta-Analysis , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[7] D. Gilbert. Serum procalcitonin levels: comment on "Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract infections in 'real life'". , 2012, Archives of internal medicine.
[8] M. Assicot,et al. High serum procalcitonin concentrations in patients with sepsis and infection , 1993, The Lancet.
[9] H. Goossens,et al. Antimicrobial Drug Use and Resistance in Europe , 2008, Emerging infectious diseases.
[10] France Gauvin,et al. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[11] B. Bein,et al. Procalcitonin-guided algorithm to reduce length of antibiotic therapy in patients with severe sepsis and septic shock , 2013, BMC Infectious Diseases.
[12] Peter Schlattmann,et al. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. , 2013, The Lancet. Infectious diseases.
[13] Anthony S McLean,et al. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. , 2007, The Lancet. Infectious diseases.
[14] K. Becker,et al. Procalcitonin assay in systemic inflammation, infection, and sepsis: Clinical utility and limitations , 2008, Critical care medicine.
[15] J. Garnacho-Montero,et al. De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock , 2013, Intensive Care Medicine.
[16] T. Bregenzer,et al. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. , 2009, JAMA.
[17] F. Tubach,et al. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial , 2010, The Lancet.
[18] P. Svoboda,et al. Can procalcitonin help us in timing of re-intervention in septic patients after multiple trauma or major surgery? , 2007, Hepato-gastroenterology.
[19] A. Marra,et al. Clinical and economic impact of procalcitonin to shorten antimicrobial therapy in septic patients with proven bacterial infection in an intensive care setting. , 2013, Diagnostic microbiology and infectious disease.
[20] M. Christ-Crain,et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. , 2006, American journal of respiratory and critical care medicine.
[21] Bryan T Grenfell,et al. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. , 2014, The Lancet. Infectious diseases.
[22] M. Christ-Crain,et al. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy. , 2007, Chest.
[23] J. Vincent,et al. Sepsis biomarkers. Value and limitations. , 2014, American journal of respiratory and critical care medicine.
[24] M. Bailey,et al. Procalcitonin algorithm in critically ill adults with undifferentiated infection or suspected sepsis. A randomized controlled trial. , 2014, American journal of respiratory and critical care medicine.
[25] J. Pugin,et al. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. , 2008, American journal of respiratory and critical care medicine.
[26] L. Rice. The Maxwell Finland Lecture: for the duration-rational antibiotic administration in an era of antimicrobial resistance and clostridium difficile. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[27] P. Olinga,et al. Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro , 2000, Critical care medicine.
[28] N. D. de Keizer,et al. External validation of Acute Physiology and Chronic Health Evaluation IV in Dutch intensive care units and comparison with Acute Physiology and Chronic Health Evaluation II and Simplified Acute Physiology Score II. , 2011, Journal of critical care.
[29] A. Armaganidis,et al. Procalcitonin-guided algorithms of antibiotic therapy in the intensive care unit: A systematic review and meta-analysis of randomized controlled trials , 2010, Critical care medicine.
[30] D. Altman,et al. Multiple significance tests: the Bonferroni method , 1995, BMJ.
[31] C. Sprung,et al. Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012 , 2013, Intensive Care Medicine.